PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12130494-5	2002	Similarly, reduced SSB repair activity in CD34(+) cells was detected following melphalan or cisplatin application.	Melphalan	79-88	CD34 molecule	Homo sapiens	42-46	
12130494-9	2002	Because CD34(+) cells also displayed higher frequencies of apoptosis in response to melphalan or cisplatin, these findings may help to explain the myelosuppression after exposure to alkylating agents.	Melphalan	84-93	CD34 molecule	Homo sapiens	8-12	
10800168-17	2000	Repeated melphalan infusion hampered subsequent CD34(+) harvests.	Melphalan	9-18	CD34 molecule	Homo sapiens	48-52	
10634173-0	1999	CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.	Melphalan	113-122	CD34 molecule	Homo sapiens	0-4	
10583236-14	1999	12 patients received a median of 3.9 x 106 CD34+ B-lin- cells/kg after conditioning with high-dose melphalan and showed a rapid reconstitution of haemopoiesis.	Melphalan	99-108	CD34 molecule	Homo sapiens	43-47	
10037044-4	1999	Lower CD34 values (P = 0.002) were seen in patients treated with potent stem cell toxins (BCNU, melphalan, CCNU and mustine), designated toxicity factor 4 agents (TF4).	Melphalan	96-105	CD34 molecule	Homo sapiens	6-10	
9827813-6	1998	Previous treatment with melphalan or carmustine was associated with a significantly lower yield of CD34-positive cells (P= 0.0001).	Melphalan	24-33	CD34 molecule	Homo sapiens	99-103	
32512672-19	2020	CONCLUSION: The increased amount of CD34+ autologous hematopoietic stem cell dose after high dose melphalan chemotherapy in MM patients shortens platelet and neutrophil engraftment time and increases overall survival.	Melphalan	98-107	CD34 molecule	Homo sapiens	36-40	
8932839-0	1996	Role of CD34+ cells in engraftment after high-dose melphalan in multiple myeloma patients given peripheral blood stem cell rescue.	Melphalan	51-60	CD34 molecule	Homo sapiens	8-12	
9692813-10	1998	Pretreatment with six or more cycles of melphalan yielded a smaller number of CD34+ cells than pretreatment with fewer than six cycles (2.5 vs 5.3 x 10(6)/kg; p = 0.001).	Melphalan	40-49	CD34 molecule	Homo sapiens	78-82